From the non-GLP RA group, 2,332,778 were excluded, resulting in 9,103,212 patients
Administration detail is important: Rybelsus must be taken on an empty stomach with limited water per its label
This approach delivers peptide directly to target tissues, bypassing skin absorption limitations entirely
When to Seek Immediate Medical Attention Severe, persistent abdominal pain (possible pancreatitis) Vision changes or eye pain (possible retinopathy) Signs of severe dehydration (dizziness, dark urine, confusion) Allergic reaction (rash, difficulty breathing, swelling) Severe hypoglycemia (confusion, sweating, rapid heartbeat) Persistent vomiting lasting more than 24 hours GLP-1 drugs are being increasingly obtained by individuals without a prescription, which makes side effects more dangerous than ever
Following GLP-1 RA initiation at the lowest dose with subsequent titration, the basal insulin dose can then be titrated based on clinical response and as informed by blood glucose monitoring (BGM) data